Strata Q1 FY26 net income returns to profit; revenue rises 87.4% to $67.4 million

Strata Critical Medical, Inc. Class A

SRTA

0.00

Strata Critical Medical Q1 2026 revenue rose 87.4% to USD 67.4 million.
Net income from continuing operations swung to profit of USD 2.4 million, with basic EPS at USD 0.03.
Gross margin widened 1.4 percentage points to 21% as gross profit more than doubled to USD 14.1 million.
Adjusted EBITDA climbed to USD 6.4 million from USD 416,000.
Completed bolt-on acquisition of Ohio Valley Perfusion Associates for about USD 1 million, opened new combined Logistics and Clinical hub in Chicago, reiterated 2026 guidance for revenue of USD 260-275 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605060700PRIMZONEFULLFEED9713955) on May 06, 2026, and is solely responsible for the information contained therein.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.